Navigation Links
FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
Date:6/11/2012

SAN DIEGO, June 11, 2012 /PRNewswire-iReach/ -- FirstMark, the diagnostic division of GenWay Biotech, announced today that Dr. Prediman K. (PK) Shah has joined it's Scientific Advisory Board.

Dr. Shah is Professor at Cedar Cedars-Sinai Professorial Series, and Director of the Division of Cardiology. He also is the Director of the Oppenheimer Atherosclerosis Research Center at Cedars-Sinai Medical Center where he leads several studies that focus on heart disease prevention and treatment. Dr. Shah holds the Shapell and Webb Family Chair in Clinical Cardiology at Cedars-Sinai. Dr. Shah has been Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) since 1992. Between 1992 and 2005, Dr. Shah and his colleagues conducted revolutionary research on mutant apo-A1 protein, called Apo-A1 Milano that produced a form of HDL that provided greater protection against atherosclerosis and vascular inflammation. In separate studies conducted, Dr. Shah found that a vaccine created from LDL significantly reduced plaque buildup in animals that had high cholesterol levels.

"We are very pleased Dr. Shah has joined FirstMark's advisory team, " said Thomas Silberg, President and CEO of GenWay Biotech. "His outstanding background in cardiovascular medicine, his focus on prevention, and his extensive experience in research will be a critical support as we continue to build clinical interest and application for FirstMark PREvent."

Dr. Shah joins the FirstMark Scientific Advisory Board that is composed of innovative and nationally recognized leaders in cardiology and research. Each of these individuals has made substantial contributions to the field of cardiology. The main focus of the Board is to provide guidance for further clinical development and validation of FirstMark's new cardiovascular test PREvent. PREvent is the first and only multiple bioma
'/>"/>

SOURCE GenWay Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
2. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
3. EMBO welcomes 55 leading life scientists as members
4. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
5. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
6. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
7. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
8. U of Alberta researcher steps closer to understand autoimmune diseases
9. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
10. UNH researchers find African farmers need better climate change data to improve farming practices
11. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... LAS VEGAS , Dec. 18, 2014   LaunchKey ... built for the post-password and Internet of Things era, ... seed funding. The venture round was led by Metamorphic ... Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader in ... biometric technology to industry leaders such as Intel, Jabra, ... validated, biometric wearable products. These products will be showcased ... Las Vegas . "Our ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... AGAWAM, Mass., May 13 Microtest Laboratories ... is adding dissolution testing to its current suite of ... services."The addition of dissolution testing ... said Steven Richter, Ph.D., President and Scientific Founder of Microtest ...
... May 20 Validus Technologies Corporation and HierStar ... formed a strategic manufacturing, marketing and distribution alliance ... Time Password (OTP) authentication products to combat cybercrime ... increasing data breaches, which have created a global ...
... scientists have identified two new genes and two new enzymes ... the plants were making monoterpenes, compounds that help give tomato ... the face of accepted thought. Such research could help ... Based on years of research, scientists thought that plants always ...
Cached Biology News:Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services 2Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services 3Validus and HierStar Form Strategic Alliance to Offer the First Complete Range of Authentication Products 2Validus and HierStar Form Strategic Alliance to Offer the First Complete Range of Authentication Products 3MSU discoveries upend traditional thinking about how plants make certain compounds 2
(Date:1/22/2015)... zFlo Motion , a US leader in biomechanics software ... a new partner. STT-Systems has developed an impressive ... with offerings in the optical-motion capture, 3D scanning, and industrial ... unit), iSen, is opening eyes around the world. With no ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Diagenode, ... such as the Bioruptor® and complete solutions for ... for chromatin immunoprecipitation, alleviating the need for manual ... controls needed for ChIP of histones or transcription ...
(Date:1/22/2015)...   GenoSpace , a precision medicine software company that has ... use of genomic, imaging and other biomedical data in research ... Munson , CEO of Aspera, an IBM Company, to its ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to welcome ...
(Date:12/24/2014)... YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. ... critical areas, announced the closing of an underwritten public offering ... up to an aggregate 3,500,000 shares of common stock, at ... warrant.  The warrants have a per share exercise price of ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... YORK, May 2 Pulmo BioTech Inc. (OTC,Bulletin Board: PLMO) ... Financial Officer., Pulmo BioTech Chief Executive Officer Garry McCann ... join the company and that Rajiv,s,experience and financial acumen would ... completion of its Phase I Human Trials and then into ...
... -- Quarterly Revenues Increase 62% to $11.7 million, ... million with EPS of $0.11, NEW YORK ... Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: ... products in China, today announced its financial results,for ...
... 7, 2008 at 10:00 AM EDT, CEDAR KNOLLS, ... ) will host a conference call discussing,its financial results ... May 7, 2008 at 10:00 AM EDT., A ... through the,company,s website at: http://www.emisphere.com . The live ...
Cached Biology Technology:Pulmo BioTech Announces Appointment of Chief Financial Officer 2Pulmo BioTech Announces Appointment of Chief Financial Officer 3China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 2China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 3China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 4China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 5China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 6China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 7China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 8China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 9Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results 2
...
... Purification with an Affinity Chitin-binding Tag) utilizes ... splicing elements (termed inteins) to purify recombinant ... (Figures 1 and 2). This system distinguishes ... its ability to separate a recombinant protein ...
... Note: The kit contains all the reagents ... of NADPH-cytochrome c reductase activity in cell ... [endoplastic reticulum (ER)]. It has been tested ... as liver, kidney, brain, spleen, and heart ...
... CHEMICON's Skeletal Myogenesis Kit provides the ... myoblasts into mature skeletal myotubes. By ... is a valuable tool in studies ... in developing strategies for muscle cell ...
Biology Products: